ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

5,967Medicare Part D Prescriptions Filled, Including Refills

Rank: 389 out of 680

$317K Total Retail Price of All Prescriptions

Rank: 413 out of 680

223 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 223 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

13% of this provider’s 223 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 5,403 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
SIMVASTATIN 335 288 1 3
AMLODIPINE BESYLATE 304 293 2 1
LEVOTHYROXINE SODIUM 288 267 3 2
OMEPRAZOLE 187 175 4 7
SYNTHROID 179 174 5 38
ATORVASTATIN CALCIUM 132 115 6 11
HYDROCODONE-ACETAMINOPHEN 127 105 S3 7 4
CITALOPRAM HBR 127 123 7 22
ALENDRONATE SODIUM 125 125 9 32
GABAPENTIN 125 125 9 15
HYDROCHLOROTHIAZIDE 113 103 11 9
METOPROLOL TARTRATE 103 97 12 12
LISINOPRIL-HYDROCHLOROTHIAZIDE 103 102 12 37
LISINOPRIL 99 87 14 5
MELOXICAM 94 74 15 24
LOSARTAN-HYDROCHLOROTHIAZIDE 93 93 16 51
ATENOLOL 90 87 17 19
METFORMIN HCL ER 84 75 18 54
METOPROLOL SUCCINATE 81 75 19 13
GLIMEPIRIDE 74 65 20 29
SERTRALINE HCL 74 67 20 28
AMITRIPTYLINE HCL 72 59 R 22 47
DONEPEZIL HCL 71 70 23 27
CRESTOR 68 66 24 25
DIOVAN 68 68 24 31
TRAMADOL HCL 66 59 26 18
FUROSEMIDE 66 63 26 6
ZOLPIDEM TARTRATE 57 55 28 17
CELEBREX 54 50 29 90
POTASSIUM CHLORIDE 52 48 30 14
CLOPIDOGREL 52 47 30 26
LOSARTAN POTASSIUM 52 51 30 21
NAMENDA 52 52 30 35
LEVOXYL 50 41 34 275
CIPROFLOXACIN HCL 50 46 34 57
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 9, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.